Sarah Gillmor Hymowitz

Sarah Gillmor Hymowitz

Genentech, Inc - South San Francisco / United States
Natural Sciences / Biological Science
AD Scientific Index ID: 4380708
-
person_outline Sarah Gillmor Hymowitz's MOST POPULAR ARTICLES
1-) ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing plateletsAJ Souers, JD Leverson, ER Boghaert, SL Ackler, ND Catron, J Chen, ...Nature medicine 19 (2), 202-208, 201326162013
2-) Regulation and functions of the IL-10 family of cytokines in inflammation and diseaseW Ouyang, S Rutz, NK Crellin, PA Valdez, SG HymowitzAnnual review of immunology 29, 71-109, 201117502011
3-) Therapeutic antibody targeting of individual Notch receptorsY Wu, C Cain-Hom, L Choy, TJ Hagenbeek, GP De Leon, Y Chen, ...Nature 464 (7291), 1052-1057, 20107852010
4-) IL‐17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL‐17F, and implications for receptor bindingSG Hymowitz, EH Filvaroff, JP Yin, J Lee, L Cai, P Risser, M Maruoka, ...The EMBO journal, 20017252001
5-) Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAILKW Wagner, EA Punnoose, T Januario, DA Lawrence, RM Pitti, ...Nature medicine 13 (9), 1070-1077, 20077142007